Inventor · disambiguated record
Vipin Suri
Also filed as: SURI VIPIN
8 granted patents·13 pending applications·66 citations·filing 2005–2024
85Inventor score
Files withOBSIDIAN THERAPEUTICS INC17CATAMARAN BIO INC1WYETH CORP1XIANG JASON S1XIANG JASON SHAOYUN1
Top patents by PatentIndex Score
21 records- 0193US11666642B2PDE5 compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2022·Granted Jun 6, 2023·9 cites·26 claims
- 0292US11241485B2PDE5 compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2018·Granted Feb 8, 2022·11 cites·26 claims
- 0390US11446398B2Regulated biocircuit systemsOBSIDIAN THERAPEUTICS INC·Filed 2017·Granted Sep 20, 2022·21 cites·7 claims
- 0488US7632838B211-beta HSD1 inhibitorsWYETH CORP·Filed 2007·Granted Dec 15, 2009·17 cites·69 claims
- 0587US12104178B2DHFR tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2021·Granted Oct 1, 2024·1 cites·7 claims
- 0687US11058725B2CA2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·5 cites·21 claims
- 0784US11629340B2DHFR tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Granted Apr 18, 2023·2 cites·29 claims
- 0877US2024401004A1Dhfr tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0958US2023233608A1Regulated biocircuit systemsOBSIDIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1057US2010029648A111-Beta HSD1 InhibitorsXIANG JASON SHAOYUN·Filed 2009·Application pending·0 cites
- 1152US2023051406A1Genetically modified natural killer cells and methods of use thereofCATAMARAN BIO INC·Filed 2021·Application pending·0 cites
- 1251US12227551B2Membrane bound IL12 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Granted Feb 18, 2025·0 cites·18 claims
- 1349US2022175781A1Cd40l compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1449US2022348937A1Compositions and methods for dhfr tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1548US2022267398A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1648US2021386788A1Er tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1746US2023092895A1Tandem cd19 car-based compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1845US2023056856A1Compositions and methods for tunable regulation of transcriptionOBSIDIAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1945US2022403001A1Pde5 derived regulatory constructs and methods of use in immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2045US2023026259A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2136US2006025445A111-Beta HSD1 inhibitorsXIANG JASON S·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vipin Suri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →